CBD for Dogs: What the Veterinary Evidence Shows

Last updated 9 August 2026 · Originally published 7 December 2022

CBD products for dogs are a large and fast-growing market, sold mainly for anxiety, arthritis pain and seizures. The evidence behind them is more interesting — and more mixed — than either the marketing or the sceptics suggest.

The short version: there’s decent evidence for seizures, promising but conflicting evidence for arthritis pain, and less for anxiety than its popularity suggests. It’s also generally well tolerated at the doses that have been studied.

Why CBD could affect dogs

Dogs, like other mammals, have an endocannabinoid system — a network of signalling molecules, enzymes and receptors involved in pain, inflammation, appetite and nervous-system activity. CBD influences that system indirectly, along with several other signalling pathways.

So there’s a biologically plausible route for CBD to affect conditions like pain and seizures. That doesn’t prove any particular product works, or tell us the right dose, but it’s why veterinary researchers take the possibility seriously rather than dismissing it.

Why controlled trials matter

You’ll sometimes read that pets can’t show placebo effects, so any improvement must be real. That isn’t right.

Veterinary trials have an additional complication called the caregiver placebo effect: owners who expect a treatment to work may perceive or report improvement even when objective measurements show little change. It’s well documented in veterinary trials, and it may be one reason owner questionnaires and objective measurements disagree.

That disagreement is the single most important thing in the canine CBD literature.

Arthritis and pain: genuinely mixed

This is where most of the research sits, and the results don’t line up neatly.

The best-known result is encouraging. A 2018 Cornell trial found that 2 mg per kilogram twice daily significantly reduced pain and increased activity in dogs with osteoarthritis — on owner assessment and on veterinary examination, with no side effects reported by owners.^[1] Some of the dogs in that study were badly affected, and their owners described real improvements in mobility.

That’s a proper randomised, placebo-controlled trial, and it’s why vets started paying attention.

Two later placebo-controlled trials, though, found nothing. One testing CBD at 4 mg/kg daily found no significant reduction in pain scores or quality of life. Another, using full-spectrum oil at 2.5 mg/kg over six weeks, found no significant difference from placebo on a standard canine osteoarthritis pain scale.

A 2025 systematic review pulled these together and reached a telling conclusion: CBD showed a significant effect on pain relief in trials using subjective assessments — owner and vet scoring — but the one study that measured pain and activity objectively, using gait analysis, found no significant improvement between treatment groups.^[2]

That difference is compatible with a caregiver placebo effect, though it doesn’t prove placebo explains the improvements. Pain questionnaires and gait analysis measure different things, and differences in dose, formulation and study design may also contribute. What it means is that confidence should stay limited until the positive results are reproduced using more objective measures.

Seizures: the strongest case

Seizures are where the canine evidence is most consistently encouraging.

Several controlled trials have tested CBD alongside conventional anti-seizure medication. They’ve generally found reductions in seizure frequency or seizure days, although not every dog responds, and the studies haven’t consistently shown the large reduction normally used to define a treatment “responder”.

In the largest published trial, involving 51 dogs with drug-resistant idiopathic epilepsy, CBD at 9 mg/kg daily reduced seizure days by 24.1%, while seizure days increased by 5.8% during placebo treatment.^[3] The number of dogs achieving at least a 50% reduction wasn’t significantly different, and liver enzymes rose during CBD treatment.

That makes CBD a credible adjunctive option rather than a replacement for established anti-seizure medication. If your dog has epilepsy it’s worth discussing with your vet — particularly because dosing, liver monitoring and interactions with existing medication all matter.

Anxiety: the most preliminary evidence

Anxiety is the most common reason owners give CBD to dogs, and it’s where the research is least developed.

A 2023 study found a single dose reduced stress-related behaviours in dogs during a car journey and being left alone — encouraging, but a single dose in a specific stressful situation.^[5] Chronic anxiety in a dog is a different problem.

Anxiety is also where caregiver placebo bites hardest, because “seems calmer” is entirely a judgement call.

Worth knowing that behavioural anxiety in dogs often responds well to training, environmental changes and, where needed, prescribed medication. A vet who deals with behaviour can help more than a supplement.

Dosing, and a warning about what you’ll read

One commonly studied arthritis dose is 2 mg per kilogram of body weight, twice daily. For a 20 kg dog that’s 40 mg twice a day. Formulations and doses differ across studies, so this isn’t a universal figure.

Be careful with figures quoted in pounds. We’ve seen the Cornell dose reported as “4.4 mg per pound” — that’s roughly five times what the study actually used. If a source gives a dose in pounds, check the arithmetic before dosing your animal.

Ask your vet about an appropriate product and dose. Rules governing what vets can recommend vary by location, but your vet should still know what your dog is taking.

Safety

CBD is generally well tolerated in dogs, but “no known danger” — another line you’ll see quoted — is wrong.

Raised liver enzymes, particularly alkaline phosphatase, appear consistently across canine studies. These changes generally haven’t been accompanied by clinical liver injury, but they may warrant monitoring — particularly at higher doses or alongside other medication.

Drowsiness, vomiting, reduced appetite and diarrhoea are commonly reported.

Drug interactions matter, and dogs on medication for seizures, pain or anything else need veterinary input.

THC is a real hazard. Dogs are considerably more sensitive to it than people, and cannabis poisoning in dogs is a genuine veterinary emergency. Human products may contain THC; some also contain xylitol, which is severely toxic to dogs.

If you’re buying

Use a product made for animals. Human formulations can contain ingredients that aren’t safe for dogs.

Insist on a batch-specific lab report. Pet CBD is as inconsistently labelled as the human market, and your dog can’t tell you the bottle was empty of active ingredient.

Look for a batch report showing non-detectable THC if you want to avoid it entirely. Category labels like “broad spectrum” don’t guarantee the contents.

Tell your vet. Especially before any procedure or blood test.

Where this leaves it

CBD isn’t snake oil for dogs, and the evidence has moved well beyond testimonials. Controlled trials suggest it can reduce seizure burden in some dogs with drug-resistant epilepsy, several arthritis studies have reported improved comfort and mobility, and short-term studies generally find it reasonably well tolerated.

The uncertainties still matter. Arthritis results haven’t held up consistently when movement is measured objectively, anxiety research remains preliminary, and different formulations may not be interchangeable. Raised liver enzymes appear often enough to justify veterinary involvement and, in some cases, monitoring.

For a dog whose seizures remain difficult to control, or whose arthritis isn’t adequately managed, CBD is a reasonable option to raise with a vet. A monitored, time-limited trial — with the intended outcome agreed in advance, such as seizure frequency or a particular mobility measure — is a sensible way to find out whether it helps your individual dog.

The fairest position isn’t to assume CBD works, or to dismiss it automatically. It’s to recognise that it has genuine therapeutic potential, use a reliable product, and judge the results as objectively as you can.

None of this is veterinary advice. Talk to your vet before giving your dog CBD, particularly if it’s on other medication.

References

Gamble LJ, Boesch JM, Frye CW, et al. Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs. Frontiers in Veterinary Science. 2018;5:165. doi:10.3389/fvets.2018.00165
Yeung T, Uquillas E. Does oral cannabidiol oil in adjunct to pain medications help reduce pain and improve locomotion in dogs with osteoarthritis? Veterinary Evidence. 2025;10(1). doi:10.18849/ve.v10i1.701
Rozental AJ, Weisbeck BG, Corsato Alvarenga I, et al. The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: a double-blinded crossover study. Journal of Veterinary Internal Medicine. 2023;37(6):2291–2300. doi:10.1111/jvim.16912
Garcia GA, Kube S, Carrera-Justiz S, et al. Safety and efficacy of cannabidiol–cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs. Frontiers in Veterinary Science. 2022;9:939966. And McGrath S, et al. Journal of the American Veterinary Medical Association. 2019;254(11):1301–1308.
Hunt ABG, Flint HE, Logan DW, King T. A single dose of cannabidiol (CBD) positively influences measures of stress in dogs during separation and car travel. Frontiers in Veterinary Science. 2023;10:1112604. doi:10.3389/fvets.2023.1112604 See also our report on the findings.

About this article

Substantially rewritten in August 2026, consolidating our earlier reporting on CBD for dogs. This update separates the evidence by condition, explains why owner-reported and objectively-measured results diverge, and corrects a widely repeated dosing figure. With earlier reporting by Jason Collins, Lydia Kariuki and Asia Mayfield.